Skip to content

Clinical trials

Phase 2/3 Fibromyalgia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibromyalgia Phase: Phase 2/3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20101
20131
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer2
Beth Israel Medical Center1
Duke University1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Tonix Pharmaceuticals, Inc.1
University of Alabama at Birmingham1
University of Cincinnati1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibromyalgia9
Chronic Pain2
Fatigue1
Fatigue Syndrome, Chronic1
Musculoskeletal Diseases1
Neuroinflammatory Diseases1
Pain1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.